Study on Beta Cell Preservation for Newly Diagnosed Ages 6-21
A new study is underway to investigate a drug to preserve beta cell function in newly diagnosed people ages 6-21.
The study is called T1GER.
From their web site:
The purpose of the T1GER clinical research study is to determine the safety and efficacy of an investigational medication in children and young adults with newly diagnosed type 1 diabetes. The investigational medication is being tested to find out if it can maintain beta cell (insulin-producing) function in the pancreas of those newly diagnosed with type 1 diabetes.
For study center locations and more information see:
Jeff Hitchcock - President and Founder, CWD
Father of Marissa (BSN, RN, CDE), now 29, married, and mother, dx'd at 24 months
25 Year Lilly Journey Award